Skip to content
Menu

Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $121

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $94 to $121.

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $94 to $121.

Read at benzinga.com

← All stock news